Edward A. Itawi

Learn More
BACKGROUND AND OBJECTIVES Alvimopan, a peripherally acting mu-opioid receptor antagonist, decreased time to gastrointestinal recovery and hospital length of stay in open bowel resection patients in Phase 3 trials. However, the benefit in laparoscopic colectomy patients remains unclear. METHODS A retrospective case series review was performed to study(More)
  • 1